Zeta Global has an ambitious growth plan, strong sales momentum, a healthy pipeline to support growth and is undervalued.

Growth in Total Revenues to $1.3 Billion for the First Quarter 2025Repurchased 1.2 Million Shares in the First Quarter 2025 DUBLIN, Calif., April 25, 2025 /PRNewswire/ ...

Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) ("Coeptis" or the "Company"), a biopharmaceutical and technology company focused on developing innovative ...